Funded Tech Companies
Fortis Therapeutics
Researching who invested in Fortis Therapeutics? Lilly Asia Ventures, Vivo Capital and Osage Partners invested in this biopharmaceutical company.
Company Overview
Company Name
Fortis Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
11099 North Torrey Pines Rd. 290
La Jolla, CA 92037
USA
La Jolla, CA 92037
USA
Phone
Website
Email Address
Not Recorded
Company Background Information
Overview
Fortis Therapeutics is an immuno-oncology biotech focused on developing new antibody drug conjugate therapies against CD46 for the treatment of late-stage multiple myeloma and late-stage prostate cancer and other indications. Fortis was founded based on technology exclusively licensed from UCSF and developed in the laboratory of Bin Liu, Ph.D.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
3/30/2021
Financing History
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jay Lichter
Chief Financial Officer
Tighe Reardon
Chief Medical Officer
Andrew Dorr
Chief Scientific Officer
Marc Nasoff
VP - Bus. Development
Leonard Post
Company Investors
- Lilly Asia Ventures
- Vivo Capital
- Osage Partners
- Bregua
- Avalon Ventures (Jay Lichter)
- Prostate Cancer Foundation
- Myeloma Investment Fund
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This venture capital transaction data comes via a partnership with VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs